Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Conditions

• Soft Tissue Infections

Interventions

• DRUG: Daptomycin
• DRUG: Vancomycin

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)